My last responce to this. But again, delaying coming

New Post Public Reply Private Reply Replies (1) Message Board
Thundersteel_03 247stat #13044
1,369
My last responce to this.

But again, delaying coming back because they are growing doesn't make sense. Does that mean as long as they are growing, they aren't coming back?

Answer: As an investor, you want the company to come back financial stable. Coming back is very easy, for the impatient, if you want dilution again.The company can trade again,without any financial foundation, and in days be wipe out/the"impatient shares out." If you can do some reasearch about book to bill ratios and beverage business, you would understand that revenues are plowed back into a company for the next product run. (To eventually get to a break even point, where a company builds a profit base and then can draw a surplus from it.) Anyone who has a business acumen/background can tell you that even if you have deals in place, that are announced, the money flows in much later after the deal is finalized. Most deals are like a credit card, where the product is shipped and then the buyer has 60-90-120 days to pay off a certain balance remaining on a deal. Some deals, like C.K. Gov contract won't be paid till mid 2018. So, they need cash flow and stability to return ,thus protecting your shares.- consisten sales on multiply fronts to have a surplus to have the cash to refile. That means c.k and other entities need several quarters of selling product.

The tipping point they think there is enough growth to come back.

Answer: When they don't need any other lender/note ,to ruin your /mine/and the companies preferred shares-f share compensation shares

Burning the sorts isn't my concern. My investment isn't based on shorts but coming back.

Answer: Your investment is tied to burning the shorts. Coming back, just to come back would allow shorts to crush your investment within days and have your shares worthless forever. If the company doesn't have constant revenue/cash flow and ongoing news and they trade, you have no investment to speak of anyways.

I just can't get a substantial answer.

Answer:Well I have given you my thoughts on each question. I know it's not easy to wait, but you have a much better shot waiting and seeing these develop then trading immediately and getting wiped out in day/days. (See my notes comment) Hjoe is not getting a traditional loan, nor will they take on notes. So, they have to build revenues through sales of distributors, c.k, and Jerky.

If you have been following, there was a delay with c.k.,last year, and they are just now starting to sell product. Without sales, there is no way to pay for the relicensing fees and legality.

I hope this helps you. If not please contact hangoverjoes or another stockholder.

I do sympathize with you. But, you also have to see this based on a business model.

P.S. there can be no official announcement or plan before notes and debts are paid. The company has to complete this task before any plans are talked about.

TS

Hangover Joe's Holding Corporation (HJOE) Stock Research Links

HJOE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 6

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 5

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 1

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 4

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 3

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Recent Developments in Consumer Technology and Trade Relations

Updated Category News Views 245

U.S.-China Trade Dynamics Chinese President Xi Jinping has emphasized ongoing developments in the trade relations between the U.S. and China. In a recent communication with President Donald Trump, both leaders discussed potential measures that could foster a positive trajectory for trade negotiations. Amid these discussions, reports surfaced that the U.S. is contemplating...

Continue Reading
HealthEquity Amid Allegations: An Investor's Guide to HQY

Updated Category News Views 244

Understanding the Investigation into HealthEquity, Inc. Pomerantz LLP is currently conducting a thorough investigation into the claims made by investors of HealthEquity, Inc. This action highlights potential concerns regarding the company’s business practices and the conduct of certain officers and directors. What Triggered the Investigation? The investigation centers...

Continue Reading
PetVivo AI Unveils Innovative Platform to Cut Client Costs

Updated Category News Views 147

Revolutionizing Veterinary Practices with AI PetVivo AI, Inc. is taking the veterinary world by storm with the introduction of PetVivo.ai, an innovative artificial intelligence platform aimed at transforming the pet care sector. With the pet care industry experiencing exponential growth—surpassing $150 billion—this platform promises to decrease client acquisition...

Continue Reading
Avery Dennison's Earnings Anticipation: What Investors Should Know

Updated Category News Views 126

Upcoming Earnings Report for Avery Dennison Avery Dennison (NYSE: AVY) is gearing up for a significant quarter, with expectations heightened ahead of its earnings announcement. Investors are eagerly awaiting the results, which could reveal crucial insights into the company's current performance and future direction. Analysts' Expectations Market analysts predict that...

Continue Reading
Understanding Recent Trends in HDFC Bank Ltd's Short Interest

Updated Category News Views 169

Recent Developments in HDFC Bank Ltd's Short Interest HDFC Bank Ltd (NYSE:HDB) has recently experienced a notable shift in its short interest. According to the latest information, short interest as a percentage of float has decreased by 3.23%. Currently, there are 15.25 million shares sold short, representing 0.3% of the available regular shares for trading. This change...

Continue Reading